CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Cash Flows from Operating Activities:
Net income (loss)			$ (867,475)	$ (5,812,234)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on investments held in Trust Account	$ (5,798)	$ (73,393)	(58,474)	(194,901)
Financing cost - derivative warrant liabilities				315,080
Change in fair value of derivative warrant liabilities	(1,138,000)	2,279,000	(3,523,000)	5,198,670
Changes in operating assets and liabilities:
Prepaid expenses			70,229	(202,187)
Accounts payable			961,084	1,329
Accrued expenses			2,575,925	26,500
Accrued expenses - related parties				17,500
Franchise tax payable			(170,411)	149,300
Net cash provided by (used in) investing activities			(1,012,122)	(500,943)
Cash Flows from Investing Activities
Cash deposited in Trust Account				(230,000,000)
Investment income released from Trust Account for working capital			300,000
Net cash used in investing activities			300,000	(230,000,000)
Cash Flows from Financing Activities:
Proceeds received from initial public offering, gross				230,000,000
Proceeds received from private placement				(4,125,486)
Offering costs paid				5,600,000
Net cash provided by financing activities				231,474,514
Net change in cash			(712,122)	973,571
Cash - beginning of the period			916,987	25,000	$ 25,000
Cash - end of the period	$ 204,865	$ 998,571	$ 204,865	998,571	$ 916,987
Supplemental disclosure of noncash activities:
Deferred underwriting commissions in connection with the initial public offering				$ 6,300,000